Laura Stiles

Levels of magnesium, folate, vitamin B12, zinc, and vitamin D 25-OH were significantly altered in children with ADHD.

Poor medication timing, incorrect doses, medication disorganization, and under- or over-medication are some of the medication adherence issues that can occur in patients with MS and cognitive symptoms.

Researchers aimed to determine the proportion of patients with early relapsing-remitting multiple sclerosis treated with natalizumab who achieve no evidence of disease activity at year 2.

A significant unmet need remains for an effective, well-tolerated, and convenient treatment for patients with progressive forms of MS.

Application of technology developed in the gaming and computer control industry offers the opportunity to create new metrics with greater sensitivity and reproducibility.

Diabetes itself, complications of diabetes, or diabetes treatment may have protective effects on the risk of migraine.

Noninvasive vagus nerve stimulation may be able to fill a gap in the treatment of cluster headaches.

These results support further testing in larger phase 3 clinical trials.

Researchers examined whether there are clinical features or treatments associated with neuropsychiatric outcomes in BECTS.

This objective score may have the potential to be an early outpatient screening tool for identifying PNES.

An emerging line of inquiry suggests a potential association between comorbidities and MS relapses, but studies have been limited.

With its 20-minute application time, the BICAMS is one of the few tools available for small centers with only a few staff members who might not be trained in administering neuropsychological tests.

A panel of clinicians from different pediatric fields have developed new guidelines for the treatment of PANS.

The update focused on diagnosis of neuropathic pain in patients with spinal cord injury, stroke, or multiple sclerosis.

The effects of dronabinol, nabilone, and nabiximols on neuropathic pain were assessed.

Researchers plan a controversial trial to use stem cells to try and reverse brain death. Plus, protective mutation A673T lends support to the amyloid hypothesis, and the molecule LRP4 may shed light on synaptic imbalances that can lead to epilepsy.

The US Food and Drug Administration requested that sodium oxybate be studied in pediatric patients.

Although nonmotor symptoms in Parkinson’s have gained significant attention through the years, blood pressure changes have been overlooked.

Long-term valbenazine may be beneficial in managing tardive dyskinesia in schizophrenia.

The extent of patients’ pain showed significant associations with age and burden of the headache.

Serum 25(OH) D levels were significantly lower in patients with chronic tension-type headache compared with in control patients.

Even minor improvements in fibromyalgia symptoms, depression, anxiety, and pain can have a significant impact on the quality of life in patients with fibromyalgia.

There is little data to support telestroke for IV thrombolysis administration in the extended time window of 3 to 4.5 hours after stroke onset.

Early onset of motor symptoms related to substance abuse appeared to significantly affect women compared with men.

There is no urgency to administer preexisting antihypertensive therapy in the first few hours or days after stroke, unless indicated for other comorbid conditions.

Underlying pathophysiological mechanisms may connect depression and epilepsy.

As dementia worsens, caregivers often have to report symptoms on behalf of the patient, and they tend to report more depressive symptoms than patients do.

Prior research has speculated that PTSD may be caused in part by an underlying REM sleep dysfunction that is amplified by OSA.

As more patients survive ICH, emphasis is slowly shifting from survival to improving ICH-related morbidity and optimization of functional recovery.

In future research, it will be important to examine whether more subtle, transient CNS changes occur in the absence of severe CNS symptoms.